Amneal Pharmaceuticals, LLC recalls Amneal — Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 1…
- Recall date
- November 22, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Amneal Pharmaceuticals, LLC, Amneal
Why it was recalled
Due to potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA — Ingredient Level
What was recalled
Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL
Read the official recall notice →
Get recall alerts
Free email alert whenever Amneal Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amneal Pharmaceuticals, LLC, Amneal